1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. New York >
  6. Sinclair Pharmaceuticals Acquires Viora

M&A Deal Summary

Sinclair Pharmaceuticals Acquires Viora

On February 4, 2022, Sinclair Pharmaceuticals acquired medical products company Viora

Acquisition Highlights
  • This is Sinclair Pharmaceuticals’ 2nd transaction in the Medical Products sector.
  • This is Sinclair Pharmaceuticals’ 2nd transaction in the United States.
  • This is Sinclair Pharmaceuticals’ 1st transaction in New York.

M&A Deal Summary
Date 2022-02-04
Target Viora
Sector Medical Products
Buyer(s) Sinclair Pharmaceuticals
Deal Type Add-on Acquisition

Target

Viora

New York, New York, United States
Viora is an operator of aesthetic solutions brands that treat a full range of aesthetic needs. With a wide array of worldwide certifications for our devices, manufacturing, and business operations (Medical ISO, CE, FDA, CFDA, KFDA, TFDA, Health Canada, Thai FDA, HAS, TGA, and more). Viora’s advanced, non-invasive products include the most advanced devices incorporating Laser, IPL, and proprietary RF technologies. Viora is based in New York City.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sinclair Pharmaceuticals

London, United Kingdom
Category Company
Sector Life Science
DESCRIPTION

Sinclair Pharmaceuticals Ltd. is an international specialty pharma company, with corporate headquarters in London, UK, and operations headquarters in Paris, France.

DEAL STATS #
Overall 3 of 3
Sector: Medical Products M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
State: New York M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-12-15 Advanced Bio-Technologies

Suwanee, Georgia, United States

Advanced Bio-Technologies, Inc. is a privately held dermatological products company that markets Kelo-cote, a patented, self-drying, silicone-based range of products for scar prevention and treatment. ABT’s flagship product, Kelo-cote Advanced Formula Scar Gel, is a proprietary silicone technology used to treat and prevent abnormal scarring such as keloid, burn and hypertrophic scars.

Buy -
Mergr

Solution for

Product

Company

Legal